002262 恩华药业
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额911,1931,008,300861,023701,1181,248,349
投资活动产生之现金流量净额(1,206,646)(293,391)(688,902)(392,522)(911,950)
筹资活动产生之现金流量净额(265,698)(210,174)(240,779)(127,434)(305,071)
汇率变动对现金及现金等价物的影响213415908(1,145)(380)
现金及现金等价物净增加/(减少)(560,938)505,150(67,750)180,01730,947
期初现金及现金等价物余额2,009,6131,504,4631,572,2121,392,1951,361,248
期末现金及现金等价物余额1,448,6752,009,6131,504,4631,572,2121,392,195